Primary care and urology patients with the male pelvic pain syndrome: Symptoms and quality of life

University of Washington Seattle, Seattle, Washington, United States
The Journal of Urology (Impact Factor: 3.75). 05/2002; 167(4):1768-73. DOI: 10.1016/S0022-5347(05)65196-8
Source: PubMed

ABSTRACT We assessed symptoms and health related quality of life in men who received prostatitis-prostatodynia diagnoses at primary care and urology visits, and compared those in whom pain-discomfort had versus had not resolved approximately 1 month later.
Telephone interviews were done with 357 men an average of 1 month after a prostatitis-prostatodynia diagnosis was made at a health maintenance organization visit. The interview included the National Institutes of Health Chronic Prostatitis Symptom Index, and pain and health related quality of life measures.
The most common pain location was the pubic-bladder area. Mean scores on most health related quality of life measures were below average, and higher pelvic pain and urinary symptom scores were associated with worse quality of life. This episode of pelvic pain was the first lifetime episode in fewer urology (22%) than primary care (38%) patients (p = 0.02). Urology patients had longer symptom episodes (p = 0.000), more days with pain in the last month (p = 0.002) and higher National Institutes of Health Chronic Prostatitis Symptom Index pain scores (p = 0.002). Men with pain in the testicles, penis or between the rectum and testicles at the visit, and with longer symptom duration before the visit were significantly more likely to have continued pain between the visit and interview.
Pelvic pain is often a persistent, recurrent condition that can have a significant negative impact on quality of life. The average symptom severity in men with pelvic pain in primary care and urology settings is lower than that in tertiary care samples.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Objectives. To investigate the effectiveness of extracorporeal shock wave therapy (ESWT) for symptoms alleviation in chronic pelvic pain syndrome (CPPS). Materials and Methods. 40 patients with CPPS were randomly allocated into either the treatment or sham group. In the first group, patients were treated by ESWT once a week for 4 weeks by a defined protocol. In the sham group, the same protocol was applied but with the probe being turned off. The follow-up assessments were done at 1, 2, 3, and 12 weeks by Visual Analogue Scale (VAS) for pain and NIH-developed Chronic Prostatitis Symptom Index (NIH-CPSI). Results. Pain domain scores at follow-up points in both treatment and sham groups were reduced, more so in the treatment group, which were significant at weeks 2, 3, and 12. Urinary scores became significantly different at weeks 3 and 12. Also, quality of life (QOL) and total NIH-CPSI scores at all four follow-up time points reduced more significantly in the treatment group as compared to the sham group. Noticeably, at week 12 a slight deterioration in all variables was observed compared to the first 3 weeks of the treatment period. Conclusions. our findings confirmed ESWT therapy as a safe and effective method in CPPS in short term.
    08/2013; 2013:972601. DOI:10.1155/2013/972601
  • [Show abstract] [Hide abstract]
    ABSTRACT: The details in timing and dynamics of inward (convergence) and outward (divergence) turning eye movements (vergence eye movements) were compared. Experiments showed that there were significant differences in the timing characteristics of convergence versus divergence movements. A model-based analysis showed that the dynamics were also different in these two vergence eye movements. Based on the assumption that these movements are driven by a neural signal composed of a pulse and a step, the gain ratio between pulse and step components was much larger than one for convergence responses, but was close to or less than one in divergence responses. These data indicate that the neural control signal for divergence is close to a simple step rather than the combined pulse-step signal in convergence
    Bioengineering Conference, 1999. Proceedings of the IEEE 25th Annual Northeast; 05/1999
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: We analyze the current status of the solution to the solar neutrino problem based both on (a) nonstandard flavor-changing neutrino interactions (FCNI) and (b) nonuniversal flavor diagonal neutrino interactions (FDNI). We find that FCNI and FDNI with matter in the Sun as well as in the Earth provide a good fit not only to the total rate measured by all solar neutrino experiments but also to the day-night and seasonal variations of the event rate, as well as the recoil electron energy spectrum measured by the SuperKamiokande Collaboration. This solution does not require massive neutrinos and neutrino mixing in vacuum. Stringent experimental constraints on FCNI from bounds on lepton flavor violating decays and on FDNI from limits on lepton universality violation rule out νe→νμ transitions induced by new physics as a solution to the solar neutrino problem. However, a solution involving νe→ντ transitions is viable and could be tested independently by the upcoming B factories if flavor violating tau decays would be observed at a rate close to the present upper bounds.
    Physical Review D 08/2000; 62(7). DOI:10.1103/PhysRevD.62.073001 · 4.86 Impact Factor